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The potential of superparamagnetic nanoparticles for biomedical applications 
has been recognized, considering their size, physicochemical properties and strong 
magnetization only when an external magnetic field is applied. The coverage of 
magnetic nanoparticles with a lipid bilayer (magnetoliposomes) improves 
biocompatibility, preserving the magnetic properties, while providing the ability to 
transport drugs. Recently, magnetic nanoparticles of manganese ferrite covered with a 
lipid bilayer were developed for drug delivery [1,2]. Plasmonic gold nanoparticles 
exhibit strong photothermal effects, producing local heat that can be exploited for 
hyperthermia and controlled drug release applications. The combination of these 
effects with a superparamagnetic behavior makes possible the development of 
multifunctional nanosystems with the capabilities of magnetic guidance, hyperthermia 
and drug delivery, with promising applications in cancer therapy.  
In this work, different types of magnetic/plasmonic MnFe2O4/Au nanoparticles 
were prepared, including core-shell and decorated nanoparticles (Fig. 1A). The 
structural, spectroscopic and magnetic properties were evaluated. The nanoparticles 
were covered with a lipid bilayer or entrapped in liposomes. These systems were 
successfully tested as nanocarriers for a potential anticancer drug (Fig. 1B), especially 
active against melanoma, breast adenocarcinoma and non-small cell lung cancer.  
 
 
Figure 1. A: TEM image of MnFe2O4/Au nanoparticles. B: Structure of the anticancer drug.  
References 
1. A. R. O. Rodrigues et al., RSC Adv. 6, 17302-17313 (2016). 
2. A. R. O. Rodrigues et al., RSC Adv. 7, 15352-15361 (2017). 
